How effective is natalizumab as second-line treatment for multiple sclerosis in daily clinical praxis?
P. S. SorensenVolume:
16
Year:
2009
Language:
english
Pages:
2
DOI:
10.1111/j.1468-1331.2008.02518.x
File:
PDF, 57 KB
english, 2009